GlassScriptPhysician profile
Jessica A Blanco
NPI 1467446377
$447,036.78
in general payments reported to CMS, 2019-2025
71 companies · $82K in 2025
The $82K reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $19K · 2021: $42K · 2022: $78K · 2023: $133K · 2024: $79K · 2025: $82K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $210K · Travel and Lodging: $67K · Food and Beverage: $16K · Education: $7.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $209,632.50 |
| Travel and Lodging | $67,177.24 |
| Food and Beverage | $16,022.83 |
| Education | $7.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $395,070.60 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Allergan, INC. | $31,494.74 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $4,088.33 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $2,185.77 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Kowa Pharmaceuticals America, INC. | $1,357.06 | 2019-2024 | Livalo, Seglentis |
| Pfizer INC. | $1,087.36 | 2019-2025 | |
| Lilly USA, LLC | $955.90 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $808.55 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $787.69 | 2022-2025 | |
| Axsome Therapeutics, INC. | $745.60 | 2024-2025 | Auvelity, Symbravo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $642.67 | 2021-2025 | Caplyta |
| Alkermes, INC. | $616.22 | 2022-2025 | Lybalvi, Aristada |
| Biohaven Pharmaceuticals, INC. | $592.52 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $507.29 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $478.50 | 2019-2025 | Trintellix |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $373.20 | 2024-2025 | Fanapt |
| Abbott Laboratories | $349.13 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2, Absolute Pro |
| Amarin Pharma, INC. | $303.38 | 2019-2021 | |
| Currax Pharmaceuticals LLC | $293.40 | 2021-2025 | Contrave, Onzetra Xsail, Nexletol |
| Merck Sharp & Dohme LLC | $267.26 | 2019-2025 | Gardasil 9, Capvaxive, Vaxneuvance |
| Embecta Corp. | $260.01 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Amgen INC. | $255.56 | 2019-2024 | Repatha, Otezla |
| Boston Scientific Corporation | $233.54 | 2020-2023 | Watchman Access System, Superion Indirect Decompression System |
| Esperion Therapeutics, INC. | $214.49 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.97 | 2019-2025 | Jardiance |
| Eisai INC. | $189.69 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $185.22 | 2019-2024 | Ajovy |
| Corcept Therapeutics | $172.95 | 2024-2025 | Korlym |
| Dermavant Sciences, INC. | $144.52 | 2023 | Vtama |
| Otsuka America Pharmaceutical, INC. | $137.64 | 2019-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $132.64 | 2019-2023 | Trulance, Xifaxan |
| Horizon Therapeutics Plc | $111.35 | 2021 | |
| Intuity Medical INC | $102.21 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Nevro Corp. | $97.31 | 2021-2022 | |
| Nalpropion Pharmaceuticals LLC | $96.22 | 2019 | |
| Exact Sciences Corporation | $94.43 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Harmony Biosciences LLC | $90.08 | 2023-2025 | Wakix |
| Therapeuticsmd, INC. | $84.08 | 2020-2021 | |
| Ucb, INC. | $84.06 | 2019 | |
| Sunovion Pharmaceuticals INC. | $80.95 | 2020-2022 | |
| Genentech USA, INC. | $80.71 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $75.55 | 2022-2023 | |
| Amneal Pharmaceuticals LLC | $71.75 | 2020-2025 | Unithroid |
| Hologic Sales and Service, LLC | $71.27 | 2019-2022 | |
| Agile Therapeutics, INC. | $70.25 | 2021-2022 | |
| Ibsa Pharma INC. | $66.22 | 2023-2025 | Licart, Flector, Tirosint |
| Dynavax Technologies Corporation | $57.46 | 2023 | Heplisav-B |
| Intra-Sana Laboratories | $49.99 | 2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Dexcom, INC. | $48.59 | 2025 | Dexcom G6 Transmitter |
| Optinose US, INC. | $35.53 | 2025 | |
| Cranial Technologies, INC | $31.44 | 2021-2023 | Doc Band |
| Lundbeck LLC | $29.56 | 2025 | Rexulti |
| Seqirus USA INC | $29.01 | 2022-2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Coloplast Corp | $28.91 | 2021 | |
| Saluda Medical Americas, INC. | $28.15 | 2023 | Evoke Scs |
| Mylan Pharmaceuticals INC. | $24.28 | 2020-2021 | |
| Phadia US INC. | $23.41 | 2024 | Immunocap |
| Dermira, INC. | $23.03 | 2020 | |
| Avion Pharmaceuticals | $21.41 | 2023 | Balcoltra |
| Alnylam Pharmaceuticals INC. | $21.17 | 2023 | Givlaari |
| Teleflex LLC | $19.63 | 2021 | |
| Janssen Pharmaceuticals, INC | $17.66 | 2021 | |
| Collegium Pharmaceutical, INC. | $16.53 | 2022 | |
| Endo Pharmaceuticals INC. | $16.45 | 2019 | |
| Astellas Pharma US INC | $16.15 | 2023 | Veozah |
| Vbi Vaccine (Delaware) INC. | $15.62 | 2022 | |
| Genzyme Corporation | $14.00 | 2022 | |
| Daiichi Sankyo INC. | $13.43 | 2020 | |
| Sun Pharmaceutical Industries INC. | $13.41 | 2023 | Ilumya |
| Hikma Pharmaceuticals USA | $11.90 | 2020 | |
| Ironwood Pharmaceuticals, INC | $11.22 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.